Rangel-Méndez, Jorge-Aarón <br/><br/>
Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.  [electronic resource] 

 -  Biomedical chromatography : BMC  Apr 2019 
 - e4462 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1099-0801 
<br/><br/><label>Standard No.: </label>10.1002/bmc.4462  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--blood<br/>Breast Neoplasms--drug therapy<br/>Chromatography, High Pressure Liquid--methods<br/>Drug Monitoring--methods<br/>Female<br/>Humans<br/>Limit of Detection<br/>Linear Models<br/>Reproducibility of Results<br/>Spectrometry, Fluorescence--methods<br/>Tamoxifen--analogs & derivatives